Bayer Aktiengesellschaft PE Ratio 2010-2024 | BAYRY
Current and historical p/e ratio for Bayer Aktiengesellschaft (BAYRY) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bayer Aktiengesellschaft PE ratio as of February 24, 2025 is 3.62.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bayer Aktiengesellschaft PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-12-27 |
4.98 |
|
inf |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharma |
$22.635B |
$51.553B |
|
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
|
